← Leaderboards
Guangdi Wang
Zenopharm, Llc
$2,293,076
Attributed
$2,293,076
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2017–19$2M$1.5M$1M$500K$0
'17
'18
'19
Funding mix
By agency
NIH$2,293,076 · 2
By mechanism
R44$1,994,552 · 1
R43$298,524 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Intramuscular”
- Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
- Manish Ishwar Shah · Baylor College Of Medicine$13,432,895
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Xinhua Li · Nano Terra, Inc.$11,841,362
- Denis Marc Daigle · Venatorx Pharmaceuticals, Inc.$7,512,530
- Fredrick Heath Damron · West Virginia University$7,012,693
Research focus
IntramuscularMetastatic Breast CancerEnsureHormone TherapyIn VivoMalignant Breast NeoplasmDrug KineticsEndocrineEstrogen ReceptorsFulvestrantIntramuscular InjectionsBioavailableBiological AvailabilityLaboratoriesDoseDrug ExposureAromatase InhibitorsChemistryBreast Cancer PatientClinical TrialsClinical ResearchFda ApprovedDosageModification